Agios Pharmaceuticals (AGIO) Accumulated Depreciation (2012 - 2016)

Agios Pharmaceuticals (AGIO) has 5 years of Accumulated Depreciation data on file, last reported at $13.4 million in Q4 2016.

• Quarterly Accumulated Depreciation rose 74.48% year-over-year to $13.4 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $13.4 million (up 74.48% YoY) and the FY2016 annual result came in at $13.4 million, up 74.48% from the prior year.
• Accumulated Depreciation rose to $13.4 million in Q4 2016, from $7.7 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $13.4 million in Q4 2016 to a low of $2.8 million in Q4 2012.
• A 5-year average of $6.7 million and a median of $5.6 million in 2014 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2014 — Accumulated Depreciation surged 32.62% — and 2016, when it jumped 74.48%.
• Tracing AGIO's Accumulated Depreciation over 5 years: stood at $2.8 million in 2012, then jumped by 52.34% to $4.2 million in 2013, then surged by 32.62% to $5.6 million in 2014, then surged by 37.89% to $7.7 million in 2015, then jumped by 74.48% to $13.4 million in 2016.
• The last three Accumulated Depreciation figures came in at $13.4 million (Q4 2016), $7.7 million (Q4 2015), and $5.6 million (Q4 2014), per Business Quant data.